Sandra K. Sauer
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 76 publications
The cumulative effect of cytogenetic abnormalities on the outcomes of myeloma patients with del(17p) undergoing AHSCT in EBMT centres between 2016 and 2022.
Journal: British journal of haematology
Published: May 15, 2026
Interpreting [18F]FDG-avid fractures after induction therapy in multiple myeloma: insights from the PET/CT sub-study of the Phase 3 GMMG-HD7 trial.
Journal: European journal of nuclear medicine and molecular imaging
Published: April 20, 2026
Standard-of-care ciltacabtagene autoleucel in earlier versus later lines of therapy for relapsed or refractory multiple myeloma: a nationwide registry analysis.
Journal: Journal of hematology & oncology
Published: April 06, 2026
Impaired hematopoiesis affects apheresis and CAR T-cell product composition and treatment response.
Journal: Transfusion
Published: December 17, 2025
Autologous haematopoietic stem cell transplantation in multiple sclerosis: outcomes and predictors from German real-world data.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 25, 2025
Fiber intake associates with increased treatment response in patients with multiple myeloma along with changes in gut microbiome.
Journal: Blood advances
Published: September 30, 2025
Validation of novel low-dose CT methods for quantifying bone marrow in the appendicular skeleton of patients with multiple myeloma: initial results from the [18F]FDG PET/CT sub-study of the Phase 3 GMMG-HD7 Trial.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 07, 2025
Quality of Life Trajectories With Integration Into Electronic Health Records for High-Resolution Patient Outcomes: Algorithm Development and Validation Study.
Journal: Journal of medical Internet research
Published: June 29, 2025
Last Updated: 09/26/2026